Sanofi (NASDAQ: SNY) is -19.85% lower on its value in year-to-date trading and has touched a low of $39.49 and a high of $57.79 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SNY stock was last observed hovering at around $40.59 in the last trading session, with the day’s loss setting it -0.65% off its average median price target of $55.55 for the next 12 months. It is also 39.76% off the consensus price target high of $66.30 offered by 25 analysts, but current levels are 6.13% higher than the price target low of $42.55 for the same period.
Currently trading at $39.94, the stock is -1.64% and -11.46% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.37 million and changing -1.60% at the moment leaves the stock -20.08% off its SMA200. SNY registered -16.15% loss for a year compared to 6-month loss of -21.19%.
The stock witnessed a -3.22% gain in the last 1 month and extending the period to 3 months gives it a -19.30%, and is -1.46% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.45% over the week and 1.46% over the month.
Sanofi (SNY) has around 95442 employees, a market worth around $100.96B and $42.03B in sales. Current P/E ratio is 15.15 and Fwd P/E is 9.05. Distance from 52-week low is 1.13% and -30.89% from its 52-week high. The company has generated returns on investments over the last 12 months (7.20%).
Sanofi (SNY) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Sanofi (SNY) is a “Overweight”. 25 analysts offering their recommendations for the stock have an average rating of 1.20, where 8 rate it as a Hold and 3 think it is a “Overweight”. 14 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Sanofi is expected to release its quarterly report on 10/28/2022.The EPS is expected to shrink by -49.30% this year.
Sanofi (SNY) Top Institutional Holders
The shares outstanding are 2.50B, and float is at 2.26B with Short Float at 0.21%.
Sanofi (SNY): Who are the competitors?
The company’s main competitors (and peers) include Eli Lilly and Company (LLY) that is trading 30.26% up over the past 12 months and Johnson & Johnson (JNJ) that is 0.71% higher over the same period. Bristol-Myers Squibb Company (BMY) is 15.26% up on the 1-year trading charts.